福泰制药Vertex Pharmaceuticals Inc. (VRTX) 2012年10-K年度报告「NASDAQ」.pdf

1、VERTEX PHARMACEUTICALS INC/MAFORM 10-K(Annual Report)Filed 03/01/13 for the Period Ending 12/31/12 Address130 WAVERLY STREETCAMBRIDGE,MA 02139-4242Telephone6173416100CIK0000875320SymbolVRTXSIC Code2834-Pharmaceutical PreparationsIndustryBiotechnology&DrugsSectorHealthcareFiscal Year12/31http:/www.ed

2、gar- Copyright 2013,EDGAR Online,Inc.All Rights Reserved.Distribution and use of this document restricted under EDGAR Online,Inc.Terms of Use.Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 _ FORM 10-K Commission file number 000-19319 _ Vertex Pharmaceuticals

3、Incorporated (Exact name of registrant as specified in its charter)Registrants telephone number,including area code(617)341-6100 _ Securities registered pursuant to Section 12(b)of the Exchange Act:Securities registered pursuant to Section 12(g)of the Exchange Act:None _ Indicate by check mark if th

4、e registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No?Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Exchange Act.Yes?No Indicate by check mark whether the registrant:(1)has filed all r

5、eports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No?Indicate by check m

6、ark whether the registrant has submitted electronically and posted on its corporate Web site,if any,every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months(or for such shorter period that the registrant was required to sub